HomeInsightsResults

Dr Reddys Laboratories Ltd Quarterly Result

Dr Reddys Laboratories Ltd Quarterly Result

stocks purchased

₹ 27.7 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

206.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 23, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Net Profit

₹ 1341.9

Last updated on: Dec 23, 2024

Key Highlights

  • The revenue of Dr Reddys Laboratories Ltd for the Sep '24 is ₹ 8351 crore as compare to the Jun '24 revenue of ₹ 7889 crore. This represent the growth of 5.8637075%.
  • The ebitda of Dr Reddys Laboratories Ltd for the Sep '24 is ₹ 2390 crore as compare to the Jun '24 ebitda of ₹ 2323 crore. This represent the growth of 2.8885105%.
  • The net profit of Dr Reddys Laboratories Ltd for the Sep '24 is ₹ 1341 crore as compare to the Jun '24 net profit of ₹ 1392 crore. This represent the decline of -3.6268313%.

Results Analysis

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20241342.45
19 Dec 20241326
18 Dec 20241275.05
17 Dec 20241248
16 Dec 20241269.9
13 Dec 20241246.3
12 Dec 20241245.95
11 Dec 20241238.45
10 Dec 20241239.95
09 Dec 20241254.8

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories allots 13,080 equity shares under ESOS

Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...

Read more

20 Dec 2024 09:31

News

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

Read more

20 Dec 2024 13:05

News

Dr Reddys launches immuno-oncology drug - Toripalimab in India

Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...

Read more

28 Nov 2024 09:14

News

Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India

Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...

Read more

28 Nov 2024 10:11

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 2024 10:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 2024 10:40

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Aug 2024

Transcript

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

July 2023

TranscriptPPT

May 2023

Transcript

Jan 2023

Transcript

Nov 2022

Transcript

June 2022

TranscriptPPT

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

May 2021

Transcript

May 2020

Transcript

Jan 2020

Transcript

FAQs for Quarterly Results of Dr Reddys Laboratories Ltd

What key financial metrics are included in Dr Reddys Laboratories Ltd's quarterly results?

Key financial metrics in Dr Reddys Laboratories Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Dr Reddys Laboratories Ltd announce its quarterly results?

Dr Reddys Laboratories Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Dr Reddys Laboratories Ltd's quarterly performance impact its stock price?

Dr Reddys Laboratories Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Dr Reddys Laboratories Ltd's quarterly results on dividends?

The impact of Dr Reddys Laboratories Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Dr Reddys Laboratories Ltd's quarterly results?

Yes, Dr Reddys Laboratories Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions